"4.58 Reference profile or reference source: is the information of a technical grade active ingredient registered under the full data, IAGT homologation, or IAGT study recognition modality and upon which the quality and hazard analysis was based and for which a regulatory decision was made and the corresponding registration was granted, and which will be used as the basis for registration by equivalence, in accordance with the provisions of this regulation. Said reference profile or reference source must correspond to the same form (TC or TK) of the IAGT for which registration by equivalence is being determined." "10.10.1. This modality only applies to IAGT (TC or TK) that do not have a reference profile or reference source in Costa Rica or whose profile approved by the SFE differs in the manufacturing form (TC or TK), which contains a chemical entity found in a registration previously granted in Costa Rica and that does not have current test data protection, as an IAGT (TC or TK) or as part of a formulated synthetic pesticide or physical vehicle and is found in the "List of authorized molecules to be registered under the IAGT modality with reference information from an internationally recognized authority", and published by the SFE. The registrant may opt for this registration modality for 4 years from the entry into force of this reform.
Products whose registrations are granted under this modality will be monitored twice a year for quality aspects by the SFE. In addition, said registration shall have a validity of 10 years, and for its renewal, the requirements indicated in numeral 14 must be submitted.
To process the registration application under this modality, the applicant must complete and submit the application form in Annex A; likewise, they must comply with the submission of all the requirements defined in Annex P of this regulation." "10.10.2. The reference information to be used will be that coming from specifications, reports, or assessments from EFSA, EPA, FAO, APVMA, Canada or New Zealand, which indicate the minimum content of the IAGT and the maximum content of relevant impurities (where they exist). In addition, this report, assessment, or specification must be the most current.
Preferably, the specification, report, or assessment from one of the indicated authorities (EFSA, EPA, FAO, APVMA, Canada or New Zealand) must be presented; however, if any of the data requested for this modality is not available in the reference information, the registrant may use another reference specification, report, or assessment from the aforementioned Authorities.
The registrant may use one or several sources from the indicated authorities, even when these present differences in the relevant impurity profile or in their maximum values, provided that the minimum IAGT content of the application is equal or greater. For cases where the relevant impurities are different or have different concentrations, the most critical value shall be adopted, and the 5-batch study must include the analysis of all relevant impurities indicated in the evaluation reports. In case it does not come with the 5-batch study, another study may be presented." "10.10.3. The toxicological, ecotoxicological, and environmental fate information for the IAGT shall be that of the information sources indicated in the previous point, provided that the minimum IAGT content of the application is equal or greater, the content of relevant impurities is equal or less, there are no new relevant impurities, and compliance with the provisions of numeral 10.10.4 is met; these must supply all the data required to complete the tables in Annex Q. Said data must coincide with the most critical value reported in the reference information and shall be used for the evaluation of the formulated synthetic pesticide.
This information shall be verified by the ecotoxicological and toxicological areas of the SFE during the IAGT registration process. Only in exceptional cases and with due technical justification, will the SFE accept for review proprietary studies from the registrant company when the reference information used does not contemplate any of the requirements indicated in Annex B and shall issue the respective report indicating the data considered approved for this IAGT. Likewise, for the data required in Annex Q, justifications issued in the specifications, reports, or assessments from EFSA, EPA, FAO, APVMA, Canada or New Zealand shall be accepted." "10.10.4.1.1 It was demonstrated through information presented by the registrant that the certified limits of all impurities greater than 1 g/kg (other than those already considered relevant) contained in their product, are non-relevant toxicologically and ecotoxicologically, as established in Annex P" "ANNEX P (Normative) REQUIREMENTS FOR THE REGISTRATION OF IAGT WITH REFERENCE INFORMATION FROM AN INTERNATIONALLY RECOGNIZED AUTHORITY.
- A)ADMINISTRATIVE SECTION OF THE FILE 1. Submit the duly completed application form for registration of Technical Grade Active Ingredient (Annex A), in each of its sections.
2. Proof of payment of the current fee.
3. Safety data sheet with its respective chemical endorsement of the technical grade active ingredient, must contain the internationally standardized requirements using the guidelines of the "Globally Harmonized System of Classification and Labelling of Chemicals (GHS, for its acronym in English) of the United Nations" as a model.
4. Label. The label must be submitted only if the IAGT is to be imported into the country. The information on the label must match what is indicated in the file.
- B)CONFIDENTIAL SECTION OF THE FILE 1. Certificate of qualitative and quantitative composition of the technical grade active ingredient issued by the parent company or by the manufacturer and signed by the responsible professional. It must be submitted signed in original or a copy certified by a notary public, which shall contain:
1.1. Minimum concentration of the technical grade active ingredient expressed as m/m percentage (or g/kg) or m/v percentage or g/L. If the concentration is indicated in m/v, the density must be declared in g/cm3 or g/mL units.
1.2. Maximum concentration of each impurity equal to or greater than one gram per kilogram (1 g/kg) or 0.1% m/m.
1.3. Maximum concentration of relevant impurities; if they are not present, their absence must be indicated.
1.4. Minimum and maximum concentration of other additives present, expressed in g/kg, g/L or percentage, when applicable and appropriate to the specific case. Must indicate the function (e.g., stabilizer).
1.5. The identity of the active ingredient, impurities and additives (the latter when applicable and appropriate to the specific case) must be indicated according to their IUPAC chemical name and the CAS number when they are available; if not available, the chemical structure must be presented.
1.6. In the event that the active ingredient is a TK, the concentration on a dry basis must also be presented, and the maximum and minimum limit must be indicated.
2. Five-batch study conducted with the IAGT intended for registration. Typically, the unidentified and unaccounted fraction of the technical grade active ingredient TC/TK must not exceed twenty grams per kilogram. The analyses and chromatograms (with their respective area) corresponding to each batch sampled must be attached and must comply with the provisions of numeral 8.1.7 regarding the presentation modality of the study. If the guide is not indicated or a different one is used, it must comply with the provisions of point 8.1.8. The results obtained in the five-batch study must comply with the limits established in the certificate of composition.
3. Justification for the determination of the manufacturing limits established for the technical grade active ingredient and impurities. The statistical bases or other technical criteria used to establish the manufacturing limits must be explained, and the respective technical justification of how they were obtained must be provided for evaluation by the SFE. In the event that it is not a statistical criterion, supporting data must be provided to further justify the technical specification. Expert criteria must be technically justified.
4. Analysis of the identity of the technical grade active ingredient compared to the standard, which shall consist of a set of analytical determinations that allow establishing the composition and constitution of the active ingredient unequivocally. To this end, two spectra of the active ingredient with their proper interpretation must be presented, chosen from among the following: IR, NMR, Mass and UV-VIS, and at least one of NMR or Mass must be presented. Both may also be presented if available. In case of doubt, the SFE, through a reasoned resolution, may request an additional test.
5. Identity of the impurities or, eventually, groups of related impurities present in the active ingredient synthesized by the manufacturer or under the manufacturer's supervision, as listed in the certificate of composition, must be identified through chemical and spectroscopic analyses with their proper interpretation that allow for the indubitable and unequivocal conclusion of the identity of each impurity or group of related impurities.
6. Justification for the presence of impurities: the registrant must provide the necessary technical explanations regarding the presence of impurities in the product. The justification must be based on chemical grounds. If the SFE determines that a relevant impurity may be present, it shall request technical justification as to why it has not been declared.
7. Analytical Methods and their respective validation used in the five-batch study, to determine impurities equal to or greater than one gram per kilogram (1 g/kg) or 0.1% m/m. Methods validated by CIPAC or other international bodies do not require analytical validation, unless they undergo alterations or modifications. " 8. Summary of the manufacturing pathway. For each process resulting in a technical grade active ingredient, the following information must be provided:
8. 1 Name and address of the manufacturer involved in the process.
8.2 General description of the process: a description written in prose which must explain the necessary steps to carry out the synthesis of the product.
8.3 Manufacturing flow diagram.
8.4 Identification of the materials used to produce the product.
8.5 General description of the conditions controlled during the process, as applicable: temperature, pressure, pH and humidity C) TECHNICAL SECTION CHEMICAL REQUIREMENTS 1. Structural formula (must include the stereochemistry of active isomers if applicable or known).
2. Analytical method and its respective validation for the determination of the purity of the technical grade active ingredient. The analytical method used in the analysis of the five batches must be presented.
3. Analytical method and its respective validation for the determination of relevant impurities, including those found below 0.1%.
TOXICOLOGICAL AND ENVIRONMENTAL REQUIREMENTS FOR THE IAGT 1. The toxicological, ecotoxicological, and environmental fate information for the IAGT, extracted from the specification or report of EFSA, EPA, FAO, APVMA, Canada or New Zealand, must be presented using the endpoint summary form from Annex Q; said data must coincide with the most critical value reported in the reference sources.
2. The registrant may optionally submit the following information:
2.1. Acute oral median lethal dose (LD50), expressed in mg/kg of body weight (OECD Technical Guideline number 423). This study shall be required in all cases unless the product is a gas or is highly volatile.
2.2. Acute dermal median lethal dose (LD50), expressed in mg/kg of body weight (OECD Technical Guideline number 402). This study shall be required unless:
2.2.1. The product is a gas or is highly volatile.
2.2.2 The product is corrosive to the skin or has a pH less than 2 or greater than 11.5 2.3. Acute inhalation median lethal concentration (LC50), expressed in mg/L of air or mg/m3, for 4 hours of exposure (OECD Technical Guideline number 403). This shall be requested when: The product is a gas or liquefied gas, is a smoke-generating preparation or a fumigant, is used with fogging equipment, is a vapor-releasing preparation, is an aerosol, is a dust containing a significant proportion of particles with a diameter less than 100 micrometers, is applied from an aircraft, contains active substances with a vapor pressure greater than 1 x 10-2 Pa and is to be used in enclosed spaces, is to be applied in a way that generates particles or droplets with a diameter less than 100 micrometers.
2.4. Dermal irritation (OECD Technical Guideline number 404). This study shall be required unless:
2. 4.1. The product is a gas or is highly volatile.
2.4.2 The product is corrosive to the skin or has a pH less than 2 or greater than 11.5.
2.5. Ocular irritation (OECD Technical Guideline number 405). This study shall be required unless:
2.5.1 The product is a gas or is highly volatile.
2.5.2 The product is corrosive to the eyes or has a pH less than 2 or greater than 11.5.
2.6. Skin sensitization (OECD Technical Guideline number 406). This study shall be required in all cases, except when: The product is known to be a skin sensitizer.
2.7. Dermal absorption of the active ingredient (Technical Guideline number 427 or 428). This study shall be submitted when exposure through the skin constitutes an important route of exposure.
The interested party may justify, based on technical and/or scientific information, the non-submission of said study, with the Competent Reviewing Authority being responsible for reviewing whether or not it is accepted.
2.8. Study on Absorption, distribution, excretion or metabolism in mammals (OECD Technical Guideline number 417).
2.8.1 This study must preferably be conducted in rats.
2.8.2 Provide information on rates and extent of absorption and distribution in different tissues.
2.8.3 Provide information on the rate and extent of excretion, including relevant metabolites.
2.8.4 Identify metabolites and the metabolic pathway.
*In particular cases, the SFE may require additional studies in other species, such as hen or goat.
2.9. Subchronic toxicological studies.
2.9.1. 90-day oral toxicity study (OECD Technical Guideline number 408).
* In particular cases, the SFE may require any of the following studies if the results of the submitted studies are considered inconclusive by the CA. 2.9.1.1 90-day oral study (OECD Technical Guideline 409).
2.9.2 28-day oral study (OECD Technical Guideline 407).
2.9.3 28-day dermal study (OECD Technical Guideline 410).
2.9.4 90-day dermal study (OECD Technical Guideline 411).
2.9.5 28-day inhalation study (OECD Technical Guideline 412).
2.9.6 90-day inhalation study (OECD Technical Guideline 413).
2.10. Genotoxic studies (mutagenicity):
2.10.1. Reverse mutation assay in bacteria (OECD Technical Guideline 471).
2.10.2. Gene mutation assay in mammalian cells (OECD Technical Guideline 476).
2.10.3. Micronucleus assay (OECD Technical Guideline 474).
2.11. Chronic toxicological studies. Long-term toxicity and carcinogenesis must be determined.
2.11.1 24-month oral carcinogenicity study (OECD Technical Guideline 451).
2.11.2. Chronic toxicity study (OECD Technical Guideline 452).
2.11.3. Combined chronic toxicity/carcinogenicity study (OECD Technical Guideline 453). * * If a combined chronic toxicity/carcinogenicity study according to OECD Guideline 453 is submitted, it is not necessary to submit the study indicated in subsections 11.1 and 11.2.
2.12. Reproduction studies.
2. 12.1. Reproductive toxicity study, using the rat as the test animal and conducted over a minimum of two generations (OECD Technical Guideline number 416).
* The SFE may require other studies, upon prior technical and duly reasoned justification, with this information being essential to proceed with the registration process. It may request complementary studies on: dominant lethal assay for male fertility; studies on cross-matings of dosed males with undosed females and vice versa; effects on spermatogenesis; effects on oogenesis; studies on sperm motility and morphology; hormonal activity study.
2.13. Teratogenicity studies (OECD Technical Guideline number 414).
2.14. Neurotoxicity studies in compounds that have effects on the nervous system.
2.14.1. If the Technical Grade Active Ingredient is an organophosphate:
2.14.1.1. Acute neurotoxicity study (OECD Technical Guideline number 418).
2.14.1.2. Subchronic delayed neurotoxicity study of 90 days (OECD Technical Guideline number 419).
2.14.2. If the Technical Grade Active Ingredient is not an organophosphate: Neurotoxicity study in rodents (OECD Technical Guideline number 424).
TOXICOLOGICAL REQUIREMENTS FOR NON-RELEVANT IMPURITIES:
In cases where the registrant demonstrates that the manufacturer intended for registration falls within the specification, report, or assessment of EFSA, EPA, FAO, APVMA, Canada or New Zealand, it shall not be necessary to demonstrate that the impurities not considered relevant greater than 1 g/kg present in their product have no toxicological relevance.
For all other cases, information must be submitted demonstrating that the impurities not considered relevant greater than 1 g/kg present in their product have no toxicological relevance. For this purpose, any of the following options may be provided:
1. Structure-activity studies or toxicological contribution analysis of the impurities.
2. Procedure established in Annex H of the Manual on Development and Use of FAO and WHO Specifications for Chemical Pesticides of 2022 or its most recent version.
3. Evaluation of the toxicological information of the IAGT to be registered must comply with the following:
The toxicological information shall be considered similar to the reference when the toxicological information provided for the new source (Toxicological Requirements for the evaluation, Annex C) does not differ by more than a factor of 2 compared to the reference data, or by a factor greater than the appropriate dose increments in the reference studies (if greater than 2). In the evaluation of studies that produce categorical results (for example, dermal irritation, ocular irritation, or sensitization), it shall be accepted that the results are equal or more favorable than the reference standard.
ECOTOXICOLOGICAL REQUIREMENTS FOR NON-RELEVANT IMPURITIES:
In cases where the registrant demonstrates that the manufacturer intended for registration falls within the specification, report, or assessment of EFSA, EPA, FAO, APVMA, Canada or New Zealand, it shall not be necessary to demonstrate that the impurities not considered relevant greater than 1 g/kg present in their product have no ecotoxicological relevance.
For all other cases, information must be submitted demonstrating that the impurities not considered relevant greater than 1 g/kg present in their product have no ecotoxicological relevance for the organisms indicated below:
1.1. Acute oral toxicity in birds. The use of guideline OCSPP 850.2100 is recommended.
1.2. Acute oral toxicity for bees. The use of guideline OECD 213 is recommended.
1.3 Acute contact toxicity for bees. The use of guideline OECD 214, OCSPP 850.3020 is recommended.
1.4 Acute toxicity in fish. The use of guideline OECD 203, OCSPP 850.1075 is recommended.
1.5 Acute toxicity in Daphnia sp. The use of guideline OECD 202 or OCSPP 850.1010 is recommended.
1.6 Effect on the growth of algae or aquatic plants. The use of guideline OECD 201, OCSPP 850.5400 is recommended.
For this purpose, any of the following options may be provided:
1. Laboratory studies with the recommended guidelines or a structure-activity study or ecotoxicological contribution analysis of the impurities.
2. Procedure established in Annex H of the Manual on Development and Use of FAO and WHO Specifications for Chemical Pesticides of 2022 or its most recent version.
3. Evaluation of the ecotoxicological information of the IAGT to be registered must comply with the following:
The ecotoxicological information shall be considered similar to the reference when the ecotoxicological information provided for the new source (Ecotoxicological Requirements, numeral 2, Annex C) does not differ by more than a factor of 5 compared to the reference (or by a factor greater than that of the appropriate dose increments, if greater than 5), when determined with the same species".
The analysis must be based on applying the provisions set forth in the document: "Procedure for the determination of the ecotoxicological equivalence of active ingredients technical grade (IAGT)" which is published on the SFE website.
"SECOND TRANSITIONAL PROVISION- The SFE will carry out a gradual registration update process where the active ingredients technical grade (ingredientes activos grado técnico, IAGT) are updated first so that the appropriate time to update formulated synthetic pesticides can be established subsequently. In the first stage, every registration of an active ingredient technical grade registered as such or as a component of a formulated synthetic pesticide granted prior to the entry into force of these regulations, must submit the information indicated in sections 10.1, 10.2, 10.3, 10.4, 10.10 and 10.11 according to the modality that suits its product and the procedure of section 11 of these regulations will be applied, with the exception of section 11.1.5 for those IAGT that have a registration number.
The information and studies cited above must belong to the product undergoing the update process, in accordance with the modality selected, and all information must be submitted and the requirements requested in the decree must be met according to the submission order and period; otherwise, the registration of the IAGT and formulated products associated with the IAGT will be cancelled, based on the provisions of section 16.12 of these regulations.
In the case of the registration modality using reference information from an internationally recognized authority, the use of referenced information from other sources will be permitted, in accordance with the provisions of section 10.10 of these regulations.
The submission order and period is as follows:
| MONTH | Molecule |
|---|---|
| Twenty-four months after the publication of this reform. | Cypermethrin, Butachlor, Dicamba, Oxadiazon, Permethrin, Thiabendazole, Tricyclazole, Tolclofos-methyl, Hydramethylnon, Phoxim, Oxamyl, Propiconazole |
| Twenty-five months after the publication of this reform. | Metsulfuron-methyl, Ametryn, Cadusafos, Diquat, Metiram, Metribuzin, Quinclorac, Esfenvalerate, Flocoumafen, Myclobutanil, |
| Twenty-six months after the publication of this reform. | MCPA, Propineb, Fenoxaprop-P-ethyl, Cyromazine, Atrazine, Thiophanate-methyl, Deltamethrin, Iprodione, Thiodicarb, Bentazone, Cartap, Propamocarb, Triclopyr, Dichloropropene, Haloxyfop-methyl, Fludioxonil |
| Twenty-seven months after the publication of this reform. | Cymoxanil, Pendimethalin, Carbaryl, Picloram, Terbutryn, Imidacloprid, Pirimiphos-methyl, Imazethapyr, Fenitrothion, Cyproconazole, Pretilachlor, Fenbuconazole, |
| Twenty-eight months after the publication of this reform. | Mancozeb, Glyphosate |
| Twenty-nine months after the publication of this reform. | Glufosinate-ammonium, Dimethomorph, Fluazifop-p-butyl, Brodifaco??? Tebuconazole, Fosetyl-aluminium, Triadimefon, Triadimenol, Fipronil, Clomazone, Terbuthylazine, Difethialone, Teflubenzuron, Diafenthiuron, Prodiamine, Flufenoxuron, Isoxaflutole, Oxadiargyl, Chlorfenapyr, Hexazinone |
| Thirty months after the publication of this reform. | Diuron, Cyhalofop-butyl, Nicosulfuron, Fluroxypyr, Imazamox, Ethoxysulfuron, Metalaxyl-M, Lufenuron, Pyrimethanil, Imazapic, Profoxydim, Lambda-Cyhalothrin, Acetochlor, Iprovalicarb, Metconazole, Fosthiazate, Methoxyfenozide, Spinosad, |
| Thirty-one months after the publication of this reform. | Indoxacarb, Famoxadone, Flazasulfuron, Zeta-Cypermethrin, Emamectin Benzoate, Trifloxysulfuron, Beta-Cyfluthrin, Thiacloprid, Fenamidone, Trifloxystrobin, Pyraclostrobin, Pymetrozine, Cyazofamid, Gamma-Cyhalothrin, Bifenthrin, Pyriproxyfen. |
| Thirty-two months after the publication of this reform. | Spiromesifen, Spiroxamine, Iodosulfuron-methyl, Carfentrazone-ethyl, Boscalid, Fenpropimorph, Aminopyralid, Kresoxim-methyl, Fomesafen, Profenofos, S-metolachlor, Ethaboxam, Fluopicolide, Epoxiconazole, Difenoconazole, |
| Thirty-three months after the publication of this reform. | 2, 4-D |
| Thirty-four months after the publication of this reform. | Thiram, Abamectin, Buprofezin, Azoxystrobin, Thiamethoxam |
| Thirty-five months after the publication of this reform. | Triazophos, Cyfluthrin, Clethodim, Benomyl, Quintozene, TCMTB, Metam-sodium, Metaldehyde, Fluvalinate |
| Thirty-six months after the publication of this reform. | Folpet, Imazapyr, Sethoxydim, Isoprothiolane, Sodium orthophenylphenate, Prochloraz, Oxyfluorfen, Ferbam, Formetanate HCl, Chloroneb, Fenamiphos, Naled, Ethoprophos, MSMA, Malathion, |
| Thirty-seven months after the publication of this reform. | Kasugamycin, Carboxin, Captan, Tetradifon, Propargite, Carbendazim, Etridiazole, Prothiofos, Thiobencarb. |
| Thirty-eight months after the publication of this reform. | Chloropicrin, Acephate, Pyrazosulfuron-ethyl, Fentin acetate, Bensulfuron-methyl, Flutolanil, Dimethoate, Piperophos, Metalaxyl, Linuron, Thiocyclam, Dazomet, Anilofos. |
| Thirty-nine months after the publication of this reform. | Propanil, Clofentezine, Zineb, Imazalil, Streptomycin, Oxytetracycline, Asulam, Hexythiazox, Maneb, Fenobucarb, Pencycuron, Sulfluramid, 2,4-DB, Gentamicin |
| Forty months after the publication of this reform. | Quaternary amine, Ziram, Etofenprox, Tebufenozide, Iprobenfos, Imibenconazole, Quaternary ammonium, Halosulfuron-methyl, Bispyribac-sodium, Acetamiprid, Dicloran, Benfuracarb, Propaquizafop, Quizalofop-p-ethyl, Validamycin A |
| Forty-one months after the publication of this reform. | Diflubenzuron, Novaluron, Fenpyroximate, Difacinone, Bromadiolone, Tridemorph, Beta-cypermethrin, Hexaconazole, Alpha-cypermethrin, Cromafenozide, Pyribenzoxim, Thifluzamide, Milbemectin, 8-Hydroxyquinoline sulfate, Copper hydroxide |
| Forty-two months after the publication of this reform. | Bordeaux mixture, Copper sulfate, Calcium hydroxide, Copper oxychloride, Mono- and di-potassium salts of phosphonic acid, Cuprous oxide, Copper oxide, Petroleum oil, Sulfur, Calcium carbonate, Copper, Sodium fluosilicate, Potassium phosphite, Aluminum phosphide, Magnesium phosphide, Silver ion, Silicon monoxide, Sodium octaborate, Copper ammonium salt, Potassium salts of fatty acids, Copper sulfate pentahydrate, Dibasic copper sulfate, Tribasic copper sulfate |
Note 1: The update will not be applied to molecules that appear on the "List of Molecules not authorized for registration under the homologation modality." Note 2: If the molecules are not included in the schedule, the SFE must be notified so that the update date is assigned in month 43 after the publication of this decree reform.
Note 3: The registration will be considered valid during the time in which the update application is being resolved.
Note 4: The update established in this transitional provision does not apply to those IAGT registrations granted through this decree, as well as those granted by Decreto Ejecutivo No. 33495 MAG-SMINAE-MEIC "Reglamento sobre Registro, Uso y Control de Plaguicidas Sintéticos Formulados, Ingrediente Activo Grado Técnico, Coadyuvantes y Sustancias Afines de Uso Agrícola", by Decreto Ejecutivo No. 42769-MAG-S-MINAE "Reglamento para optar por el Registro de Ingrediente Activo Grado Técnico mediante el reconocimiento de la evaluación de los estudios técnicos aprobados por las Autoridades Reguladoras de los países miembros de la OCDE y los países adherentes de la OCDE", and Decreto Ejecutivo No. 43469 MAG-MINAE-S "Reglamento para el Registro de Insumos Agrícolas. Plaguicidas Sintéticos Formulados, Ingrediente Activo Grado Técnico, Coadyuvantes, Sustancias afines y Vehículos Físicos de Uso Agrícola". For these purposes, the registrant must submit a note to the SFE indicating the regulation under which it was registered.
Note 5: For every update of an active ingredient technical grade as a component of a formulated synthetic pesticide or chemical pesticide of mineral or inorganic origin, the registration of the active ingredient technical grade will be granted upon compliance with this transitional provision, provided that the analysis and evaluation of the information submitted is in accordance with the provisions of these regulations.
Note 6: Likewise, the applicant may provide any additional documentation beyond what is requested in this transitional provision, in order to accredit further information on the active ingredient technical grade, registered as such or as a component of a formulated synthetic pesticide." Note 7: When the update month according to the aforementioned schedule arrives and the SFE does not have a reference profile, the registration modality using reference information from internationally recognized authorities will apply to that molecule, and a period of 9 additional months will be granted for its submission. Should the SFE have the reference profile in the month corresponding to its update or in the three months prior, registrants will have 6 additional months for the update under the equivalence modality."